Program Description

Applications may be submitted under one of two options:

Multi-Government Support (pursuant to Section 5 of the International Procedure):

• Neither partner provides the other with funding for their program expenses
• The foreign partner is not an academic/research institution or a subsidiary, affiliate, or entity owned/controlled (directly or indirectly) by an academic/research institution. However, an academic/research institution may participate as a subcontractor of the foreign partner or as a member of a consortium that includes the foreign partner.
• Under multi-government support, it is also possible to apply for approval of an international program without receiving a grant from the Innovation Authority, the same rules and provisions of the International Procedure and Benefit Program apply to such applications as well.

Available regions for multi-government support applications:

Asia

Shandong, China (All technology fields)

Shandong is a vibrant hub of traditional industry and an emerging global force in technological innovation. Key strengths include renewable energy, smart manufacturing, marine technologies, and biotechnology.

• View guidelines here

Taiwan (All technology fields)

Taiwan is a global leader in high-tech industries, with breakthroughs in Smart Technology, Advanced Manufacturing, Biotechnology and Medical Technology, Green Energy and Circular Economy, and Service Innovation. Its stable economy and strong academia-industry collaboration make it an ideal dynamic environment for R&D and pilots in new technologies. 

• View guidelines here

Thailand (All technology fields)

Thailand’s strategic location makes it an ideal gateway to the thriving economies of Southeast Asia, while also being a vibrant and dynamic hub for innovation and technology in its own right. Local market expertise in key sectors such as agriculture, tourism, and smart manufacturing makes the Thai ecosystem a fertile environment for deploying innovative technological solutions tailored to large-scale emerging markets. Collaboration with Thai companies therefore opens the door to a dynamic market that encourages sustainable growth and opportunities for expansion. This program is open to pilot programs only.

• View guidelines here

Americas

Curiosity Lab

 A living lab connecting transportation infrastructure, logistics, and other advanced technologies within an active city and real-world environment. Located in Peachtree Corners, metro Atlanta, Georgia. Works with startups, corporate innovation teams, universities, and global partners to deploy and validate next-generation technologies under real operating conditions. This collaboration requires submission of a preliminary application to be reviewed by the American side to assess fit before advancing to a full funding application with the Authority. Submit the preliminary application via the Curiosity Lab – Technology Deployment Application form by June 1, 2026. 

• View guidelines here

Europe

Germany (All technology fields)

Germany is the EU’s largest economy and one of the world’s leading ones, currently undergoing significant structural changes affecting industry — including industrial transformation, transition to renewable energy, accelerated digitalization, and supply chain shifts — presenting both considerable challenges and new opportunities for Israeli companies.

• View guidelines here

Eureka

Eureka is the European Innovation Network that offers collaborations with its partners in all technological fields:
ITEA4  – software-based systems 
CELTIC-NEXT – Focus on Information and Communications Technology (ICT) sector
XECS– electronic systems and components
SMART– advanced manufacturing 
EUROGIA– energy sector

Collaboration with a Foreign Partner who is a Party to an International Agreement (pursuant to Section 6 of the International Procedure)

• The foreign partner’s contribution (in cash or in kind) must be at least equal to the grant approved by the Innovation Authority for the applicant, and this contribution shall not be considered supplementary financing for the program.
• For the avoidance of doubt, supplementary financing must come from a separate private source that is not the foreign partner.
• This collaboration is within the framework of Multinational Corporations (MNCs) partnerships. 

Special partners requiring preliminary submission:

AstraZeneca – AstraZeneca is a leading global pharma company focused on oncology, lung diseases, rare diseases, immunology, and cardiovascular diseases. Beam is a global real-world evidence research center led by AstraZeneca, established in collaboration with Tel Aviv University. It promotes high-quality research leveraging decades of high-quality Israeli health data to drive insights and advance patient care in Israel and worldwide. Israeli companies and startups are invited to submit a 1–2 page description of the proposed technology and potential projects of interest to AstraZeneca-Beam. A dedicated team will carefully evaluate proposals and select those to advance to the next stage.

• Submit preliminary applications to: [email protected] by June 3, 2026. 
• View guidelines here

Hyundai – A preliminary EOI form is required for those interested in collaboration with Hyundai. Submit the EOI form by May 15, 2026.

• View guidelines here 

Criteria

Eligibility Criteria 

• The applicant is an industrial corporation that has submitted an application for R&D support under an international program with a foreign partner for an execution period not exceeding 24 months, with a signed Letter of Intent (LOI) covering division of work, ownership of knowledge, and commercialization rights, including use of and access to program results. Note: in a pilot program, intellectual property remains with the Israeli applicant company. 
• A foreign partner under a multi-government support application must be from the regions listed above; a foreign partner under an international agreement application must be from the corporations listed above. 
• All R&D under the program must be carried out in Israel by Israeli residents, unless the Research Committee is convinced (with documented reasons) that part of the program must be performed outside Israel or by non-residents. If the applicant is the sole owner of all knowledge and IP arising from the program, the Innovation Authority grant may be used to pay for the foreign partner’s contribution to the program, in accordance with the subcontractor payment provisions. 
• The applicant must not have a pending application for funding the same program (in whole or in part) under any Innovation Authority benefit Program or sub-program. 
• No financial assistance from a government body or the Innovation Authority (directly or indirectly) has been received for the project, other than under this Benefit Program. No additional benefit will be granted for a project that has previously received a benefit under this program. 
• The applicant must not have restricted bank accounts and must not be undergoing receivership, proceedings stay, liquidation, or similar proceedings. 
• The applicant and its controlling shareholders must comply with the Regulations for the Encouragement of Industrial R&D (Conditioning of Approvals – Minimum Wage), 5771-2011. 
• If the Innovation Authority has designated the application process under Section 4.2 of the Benefit Program, the applicant or application must meet those requirements. 
• Remaining eligibility criteria are detailed in the International Procedure and the Benefit Program. 

Evaluation Criteria 

• Technological aspect: Level of functional and technological innovation, complexity and depth, technological challenges, and technological feasibility. 
• Business aspect: Business and economic growth potential, including market potential, market size/growth rate, competitive advantage (including IP strength), and market validation performed. 
• Economic aspect: Incremental return to the Israeli economy, including high market entry barriers and potential to grow a complete company in Israel. 
• Applicant capabilities: Ability to successfully complete the program, including managerial, technological/engineering, and business/marketing capabilities, and achievements to date. 
• Challenge response: If the Research Committee designated the process under Section 4.2.z. of the Benefit Program, the degree to which the program addresses the published challenge. 

Application Process

Attachments